MISONIDAZOLE AND RADIOTHERAPY (RT) IN THE TREATMENT OF MALIGNANT GLIOMA - A PHASE-II TRIAL

被引：0
|
作者：
WEINSTEIN, AS
ALAVI, JB
BRUNO, LA
CARABELL, SC
CHANG, CH
GOODMAN, RL
机构：
[1] UNIV PENN,PHILADELPHIA,PA 19104
[2] COLUMBIA PRESBYTERIAN MED CTR,NEW YORK,NY 10032
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1980年 / 21卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：396 / 396
页数：1
相关论文
共 50 条
  • [41] ACCELERATED HYPERFRACTIONATED RADIATION-THERAPY FOR MALIGNANT GLIOMA - A PHASE-II STUDY
    JEREMIC, B
    GRUJICIC, D
    ANTUNOVIC, V
    DJURIC, L
    SHIBAMOTO, Y
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (05): : 449 - 453
  • [42] Phase II trial of imatinib mesylate plus hydroxyurea in the treatment of patients with malignant glioma
    Reardon, D
    Friedman, A
    Herndon, J
    Quinn, J
    Rich, J
    Vredenburgh, J
    Badruddoja, M
    Desjardins, A
    Sampson, J
    Gururangan, S
    Dowell, J
    Affronti, M
    Allen, D
    Jackson, S
    Zeigler, K
    Silverman, S
    Tourt-Uhlig, S
    Silverman, S
    Salvado, A
    Nikolova, Z
    Bigner, D
    Friedman, H
    NEURO-ONCOLOGY, 2004, 6 (04) : 381 - 381
  • [43] PHASE-II TRIAL OF MENOGARIL IN ADVANCED MALIGNANT-MELANOMA - AN EORTC TRIAL
    GUNDERSEN, S
    MONFARDINI, S
    RENARD, G
    VANGLABBEKE, M
    PINEDO, H
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (11): : 1707 - 1708
  • [44] PHASE-II TRIAL OF MISONIDAZOLE (MISO) AND CYCLOPHOSPHAMIDE (CYC) IN METASTATIC RENAL-CELL CARCINOMA
    GLOVER, D
    TRUMP, D
    KVOLS, L
    ELSON, P
    VOGL, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (08): : 1405 - 1408
  • [45] PHASE-II TRIAL OF MVE-II IN METASTIC MALIGNANT-MELANOMA
    RINEHART, J
    LAFORGE, J
    GOCHNOUR, D
    NEIDHART, J
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1987, 24 (03) : 244 - 246
  • [46] Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
    Vredenburgh, James J.
    Desjardins, Annick
    Herndon, James E., II
    Dowel, Jeannette M.
    Reardon, David A.
    Quinn, Jennifer A.
    Rich, Jeremy N.
    Sathornsumetee, Sith
    Gururangan, Sridharan
    Wagner, Melissa
    Bigner, Darell D.
    Friedman, Allan H.
    Friedman, Henry S.
    CLINICAL CANCER RESEARCH, 2007, 13 (04) : 1253 - 1259
  • [47] PHASE-II TRIAL FOR COMBINED EXTERNAL RADIOTHERAPY AND HYPERTHERMIA FOR UNRESECTABLE HEPATOMA
    KIM, BS
    CHUNG, HC
    SEONG, JS
    SUH, CO
    KIM, GE
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 : S119 - S127
  • [48] NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients
    Ali, Arif N.
    Zhang, Peixin
    Yung, W. K. Alfred
    Chen, Yuhchyau
    Movsas, Benjamin
    Urtasun, Raul C.
    Jones, Christopher U.
    Choi, Kwang N.
    Michalski, Jeff M.
    Fischbach, A. Jennifer
    Markoe, Arnold M.
    Schultz, Christopher J.
    Penas-Prado, Marta
    Garg, Madhur K.
    Hartford, Alan C.
    Kim, Harold E.
    Won, Minhee
    Curran, Walter J., Jr.
    JOURNAL OF NEURO-ONCOLOGY, 2018, 137 (01) : 39 - 47
  • [49] NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients
    Arif N. Ali
    Peixin Zhang
    W. K. Alfred Yung
    Yuhchyau Chen
    Benjamin Movsas
    Raul C. Urtasun
    Christopher U. Jones
    Kwang N. Choi
    Jeff M. Michalski
    A. Jennifer Fischbach
    Arnold M. Markoe
    Christopher J. Schultz
    Marta Penas-Prado
    Madhur K. Garg
    Alan C. Hartford
    Harold E. Kim
    Minhee Won
    Walter J. Curran
    Journal of Neuro-Oncology, 2018, 137 : 39 - 47
  • [50] ORAL ETOPOSIDE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA - A PHASE-II STUDY
    TAMMILEHTO, L
    MAASILTA, P
    MANTYLA, H
    SALO, J
    MATTSON, K
    ANNALS OF ONCOLOGY, 1994, 5 (10) : 949 - 950
12345